Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2014, Article ID 864317, 6 pages
http://dx.doi.org/10.1155/2014/864317
Research Article

Usefulness of Lipid Apheresis in the Treatment of Familial Hypercholesterolemia

1Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, 920 E 28th Street, Minneapolis, MN 55407, USA
2Minneapolis Heart Institute at Abbott Northwestern Hospital, 920 E 28th Street, Minneapolis, MN 55407, USA
3Kidney Specialists of Minnesota at Abbott Northwestern Hospital, 920 E 28th Street, Minneapolis, MN 55407, USA

Received 9 June 2014; Revised 6 August 2014; Accepted 7 October 2014; Published 19 October 2014

Academic Editor: Shinichi Oikawa

Copyright © 2014 Matthew Lui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. R. Thompson, “LDL apheresis,” Atherosclerosis, vol. 167, no. 1, pp. 1–13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Schuff-Werner, H. Gohlke, U. Bartmann et al., “The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease,” European Journal of Clinical Investigation, vol. 24, no. 11, pp. 724–732, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. Expert Panel on Detection; Evaluation; and Treatment of High Blood Cholesterol in Adults, “Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” The Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar
  4. Pathobiological Determinants of Atherosclerosis in the Youth (PDAY) Research Group, “Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking,” Journal of the American Medical Association, vol. 264, no. 23, pp. 3018–3024, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Whitfield, P. H. R. Barrett, F. M. van Bockxmeer, and J. R. Burnett, “Lipid disorders and mutations in the APOB gene,” Clinical Chemistry, vol. 50, no. 10, pp. 1725–1732, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. D. Horton, J. C. Cohen, and H. H. Hobbs, “PCSK9: a convertase that coordinates LDL catabolism,” The Journal of Lipid Research, vol. 50, pp. S172–S177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. S. Brown and J. L. Goldstein, “A receptor-mediated pathway for cholesterol homeostasis,” Science, vol. 232, no. 4746, pp. 34–47, 1986. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Goldstein, H. H. Hobbs, and M. S. Brown, “Familial hypercholesterolemia,” in The Metabolic and Molecular Basis of Inherited Disease, C. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, Eds., pp. 2863–2913, McGraw Hill, New York, NY, USA, 2001. View at Google Scholar
  9. U.S. Food and Drug Administration (FDA), PMA final decisions rendered for September 1997, http://www.accessdata.fda.gov/cdrh_docs/pdf/p940016.pdf.
  10. P. N. Hopkins, P. P. Toth, C. M. Ballantyne, and D. J. Rader, “Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia,” Journal of Clinical Lipidology, vol. 5, no. 3, pp. S9–S17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Tamai, H. Matsuoka, H. Itabe, Y. Wada, K. Kohno, and T. Imaizumi, “Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans,” Circulation, vol. 95, no. 1, pp. 76–82, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. K.-P. Mellwig, D. Baller, U. Gleichmann et al., “Improvement of coronary vasodilatation capacity through single LDL apheresis,” Atherosclerosis, vol. 139, no. 1, pp. 173–178, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Sato and I. Amano, “Changes in oxidative stress and microcirculation by low-density lipoprotein apheresis,” Therapeutic Apheresis, vol. 7, no. 4, pp. 419–424, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Kobayashi, K. Yamashita, H. Tasaki et al., “Evaluation of improved coronary flow velocity reserve using transthoracic Doppler echocardiography after single LDL apheresis,” Therapeutic Apheresis and Dialysis, vol. 8, no. 5, pp. 383–389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Tatamia, N. Inoue, H. Itoh et al., “Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study,” Atherosclerosis, vol. 95, no. 1, pp. 1–13, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Matsuzaki, K. Hiramori, T. Imaizumi et al., “Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the low density lipoprotein-apheresis coronary morphology and reserve trial (LACMART),” Journal of the American College of Cardiology, vol. 40, no. 2, pp. 220–227, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Kroon, W. R. M. Aengevaeren, T. van der Werf et al., “LDL-apheresis atherosclerosis regression study (LAARS): effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis,” Circulation, vol. 93, no. 10, pp. 1826–1835, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. G. R. Thompson, V. M. G. Maher, S. Matthews et al., “Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis,” The Lancet, vol. 345, no. 8953, pp. 811–816, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Masaki, R. Tatami, T. Kumamoto et al., “Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy,” International Heart Journal, vol. 46, no. 5, pp. 833–843, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. F. van Buuren, S. Kreickmann, D. Horstkotte, T. Kottmann, and K. P. Mellwig, “HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures,” Clinical Research in Cardiology Supplements, vol. 7, no. 1, pp. 24–30, 2012. View at Publisher · View at Google Scholar · View at Scopus